Feb 12 (Reuters) - Axovant Sciences Ltd on Monday said Chief Executive Officer David Hung had resigned, nearly a year after his appointment and a month after the drug developer scrapped a key clinical program.
Date: Feb 12, 2018
Category: Business
Source: Google
Axovant's lead Alzheimer's drug flops in PhIII, ending an unlikely quest
illions of patients and families impacted by Alzheimers disease. However, we believe that the fight against Alzheimers and other important areas of unmet need in neurology is too important to be derailed by this setback, said David Hung, chief executive officer of Axovant, in a statement.
Date: Sep 26, 2017
Category: Health
Source: Google
Clovis set to challenge AZ with early PARP approval Rubraca
Before his company'ssale to Pfizer for $14 billion, Medivation CEO David Hung described his companys candidate, talazoparib, as best-in-class PARP med. Then, when Tesaro rolled out its data, investors responded by sending Medivations shares north.
Date: Dec 19, 2016
Category: Health
Source: Google
For sale: $38M BC mansion bought for $9.5M in 2014
The Gables Estate, located on Southwest Marine Drive, is the largest and most private property available in Vancouver according to David Hung, the homes realtor. The mansion sits on 4.25 acres of manicured lawns and includes two golf greens, an outdoor fire pit and a private lake.
Date: Oct 12, 2016
Source: Google
Pfizer, AZ feel the heat as Tesaro wows with stellar PARP data
The California biotechs CEO, David Hung, has trumpeted Medivations talazoparib as a best-in-class PARP player, a mantra that got plenty of airtime while Big Pharmas including Sanofi, Amgen, Novartis, AstraZeneca and others were reportedly weighing bids.
Date: Oct 08, 2016
Category: Health
Source: Google
All bets are on for biotech deals after $14B Medivation bonanza
Everyone knew that Medivation ($MDVN) would be bought in the end, but the big question was how long could David Hung, the Californian firms CEO, push back the perceived lowball offers from Sanofi and get the $10-billion-plus he was clearly seeking?
Date: Aug 23, 2016
Category: Business
Source: Google
Pfizer (PFE) to Acquire Medivation (MDVN) in $14B Deal
We believe the combination with Pfizer is the right next step in our growth trajectory and is a testament to the passion and dedication by which the Medivation team has delivered on our mission to profoundly transform patients lives through medically innovative therapies, said David Hung, M.D., f
Date: Aug 22, 2016
Category: Business
Source: Google
Pfizer ready to shell out $14B for most-wanted M&A target Medivation: FT
In kicking back against Sanofis offers, Medivation CEO David Hung has argued repeatedly that his company is worth far more. The fast-moving Xtandi, which is expected to bring in $1.52 billion in sales for Medivation this year, has a massive market opportunity in its current prostate cancer indica